VIB is a research institute located in Flanders, Belgium. VIB was founded by the Flemish government in 1995, and became a full-fledged institute on 1 January 1996
The Latest Bing News on:
Flanders Institute of Biotechnology (VIB) Research
- FDA halts testing of Beam’s base editing cancer therapy
The regulator has put on hold human testing of a blood cancer treatment known as BEAM-201, one of two that the biotech aims to bring to clinical trials this year.
- La Jolla Institute for Immunology Acquires the Carterra LSA Platform to Advance State-of-the-Art Immunological and Infectious Disease Research
Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology (LJI), a globally recognized non-profit research organization ...
- Information On The Total Number Of Voting Rights And Shares
Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in ...
- Information on the total number of voting rights and shares
Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in ...
- Recording the Brain at Work with Thousands of Sensors
More recently additional funders have included The Flemish Institute for Biotechnology (VIB) and the Katholieke Universiteit Leuven (KUL) through Neuroelectronics Research Flanders (NERF), The ...
The Latest Google Headlines on:
Flanders Institute of Biotechnology (VIB) Research
The Latest Bing News on:
Flanders Institute of Biotechnology (VIB) Discovery
- Acticor Biotech obtains "PRIME" status from the European Medicines Agency for glenzocimab in the treatment of stroke
ACTICOR BIOTECH (Paris:ALACT) (ISIN: FR0014005OJ5 - ALACT), a clinical-stage biotechnology company developing innovative drugs for the treatment of cardiovascular emergencies, in particular stroke, ...
- The secretases: enzymes with therapeutic potential in Alzheimer disease
The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD). Three proteases that are involved in the processing ...
){kind=link}